Page last updated: 2024-12-06

leucogentian violet

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

leucogentian violet: metabolite of gentian violet; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID69048
CHEMBL ID81595
CHEBI ID182175
SCHEMBL ID61574
MeSH IDM0124076

Synonyms (71)

Synonym
CHEMBL81595
4-[bis[4-(dimethylamino)phenyl]methyl]-n,n-dimethylaniline
CHEBI:182175
4,4''-methylidynetris(n,n-dimethylaniline)
tris[4-(dimethylamino)phenyl]methane
4,4''-(hexamethyltriamino)triphenylmethane
crystal violet leucobase
603-48-5
4,4''-tris(n,n-dimethylaminophenyl)methane
leucocrystal violet
benzenamine,4',4''-methylidynetris[n,n-dimethyl-
nsc7338
leucomethyl green
nsc-7338
4,4''-tris(dimethylamino)triphenylmethane
c.i. basic violet 3, leuco
aniline,4',4''-methylidynetris[n,n-dimethyl-
tris(p-dimethylaminophenyl)methane
benzenamine, 4,4',4''-methylidynetris[n,n-dimethyl-
aniline, 4,4',4''-methylidynetris[n,n-dimethyl-
leuco crystal violet
4,4',4''-methylidynetris(n,n-dimethylaniline)
M0344
tris(4-dimethylaminophenyl)methane
(4-{bis[4-(dimethylamino)phenyl]methyl}phenyl)dimethylamine
n,n,n',n',n'',n''-hexamethyl-4,4',4''-methylidynetrianiline
benzenamine, 4,4',4''-methylidynetris(n,n-dimethyl-
aniline, 4,4',4''-methylidynetris(n,n-dimethyl-
unii-3lbr3lr8fs
4,4',4''-tris(n,n-dimethylaminophenyl)methane
ai3-19978
tris(4-(dimethylamino)phenyl)methane
3lbr3lr8fs ,
4,4',4''-(hexamethyltriamino)triphenylmethane
nsc 7338
4,4',4''-tris(dimethylamino)triphenylmethane
leucogentian violet
einecs 210-043-9
FT-0670766
FT-0627799
3VW1
AKOS015903459
4-{bis[4-(dimethylamino)phenyl]methyl}-n,n-dimethylaniline
SCHEMBL61574
DTXSID3060530
W-105258
n-(4-(bis[4-(dimethylamino)phenyl]methyl)phenyl)-n,n-dimethylamine #
tris[4-dimethylaminophenyl]methane
p,p',p''-methylidynetris(n,n-dimethylaniline)
4,4,4-methylidynetris-(n,n-dimethylaniline)
tris[p-(dimethylamino)phenyl]methane
4,4',4''-methanetriyltris(n,n-dimethylaniline)
STL416656
mfcd00008314
AS-66577
CS-8215
leuco cristal violet
HY-D0233
lcv ,
a-dma
leuco basic violet 3
crystal violet leuco base
p,p',p''-methylidynetris(n,n-dimethyl-aniline
4,4',4''-methylidynetris(n,n-dimethylbenzenamine)
ci basic violet 3, leuco
D91321
A868995
leuco gentian violet
4,4',4'-methylidynetris(n,n-dimethylaniline)
SY012880
PD065506

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Leucogentian violet, amounting to 11% of the total radioactivity, was also detected by HPLC in ether extracts of feces collected from a female Fischer 344 rat dosed orally for 4 days with 14C-labeled gentian violet."( Biotransformation of gentian violet to leucogentian violet by human, rat, and chicken intestinal microflora.
Cerniglia, CE; McDonald, JJ,
)
1.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzenoid aromatic compound
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2013Nature communications, , Volume: 4The crystal structure of multidrug-resistance regulator RamR with multiple drugs.
AID214649Natural log of the value in (uM) of inhibition constant was tested against Trypanothione Reductase1997Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
A virtual screening approach applied to the search for trypanothione reductase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.23)18.7374
1990's5 (16.13)18.2507
2000's7 (22.58)29.6817
2010's17 (54.84)24.3611
2020's1 (3.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.67 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index5.20 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.56%)5.53%
Reviews1 (2.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other37 (94.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]